首页> 外国专利> SUBSTITUTED DIHYDRO, TRIHYDRO AND TETRAHYDRO CYCLOALKYLOXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF AS ALLOSTERIC MODULATORS OF MGLUR

SUBSTITUTED DIHYDRO, TRIHYDRO AND TETRAHYDRO CYCLOALKYLOXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF AS ALLOSTERIC MODULATORS OF MGLUR

机译:取代的二氢,三氢和四氢环烷基氧杂唑并嘧啶酮类化合物的制备及其用作MGLUR的异位调节剂

摘要

The present invention relates to a series of 2-substituted-di- tri or tetra-hydro-8H-cyclopentaoxazolo[3,2-a]pyrimidin-8-ones and 2-substituted-di-, tetra-, or hexa-hydro-cyclohexaoxazolo[3,2-a]pyrimidin-9-ones of formula (I). Wherein p, n, A, B, X, Y, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined herein. This invention also relates to methods of making these compounds including novel intermediates. The compounds of this invention are modulators of metabotropic glutamate receptors (mGluR), particularly, mGluR2 receptor. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic neurodegenerative conditions, psychoses, convulsions, anxiety, depression, migraine, pain, sleep disorders and emesis.
机译:本发明涉及一系列2-取代的二-三或四氢-8H-环五恶唑并[3,2-a]嘧啶-8-酮和2-取代的二-,四或六氢式(I)的-环己恶唑并[3,2-a]嘧啶-9-。其中p,n,A,B,X,Y,R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8如本文所定义。本发明还涉及制备包括新型中间体的这些化合物的方法。本发明的化合物是代谢型谷氨酸受体(mGluR),特别是mGluR2受体的调节剂。因此,本发明的化合物可用作药物,尤其是用于治疗和/或预防多种中枢神经系统疾病(CNS),包括但不限于急性和慢性神经退行性疾病,精神病,惊厥,焦虑症,抑郁,偏头痛,疼痛,睡眠障碍和呕吐。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号